Lobbying Disclosure Act of 1995 (Section 5) - All Filers Are Required to Complete This Page

9. Check if this filing amends a previously filed version of this report

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code BUD

16. Specific lobbying issues

S. 1790, National Defense Authorization Act for Fiscal Year 2020, provisions relating to uniformed medical staff cuts
CDC funding for gun violence research, mental health, and suicide prevention

17. House(s) of Congress and Federal agencies Check if None

U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code HCR

16. Specific lobbying issues

H.R. 3502, Protecting People From Surprise Medical Bills Act, all provisions
H.R. 3630, No Surprises Act, all provisions
S. 1531, Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019, all provisions
H.R. 2328, Community Health Investment, Modernization, and Excellence Act of 2019, all provisions
S. 1895, Lower Health Care Costs Act, all provisions
H.R. 2279, Safe Step Act, all provisions
H.R. 2339, Reversing the Youth Tobacco Epidemic Act of 2019, all provisions
H.R. 1503, Orange Book Transparency Act of 2019, all provisions
H.R. 1520, Purple Book Continuity Act of 2019, all provisions
H.R. 987, Strengthening Health Care and Lowering Prescription Drug Costs Act, all provisions
S. 2032, Cannabidiol and Marihuana Research Expansion Act, all provisions

21st Century Cures Act
21st Century Cures 2.0
Affordable Care Act/stabilization
Surprise Billing
Nomination of Stephen Hahn, MD, as FDA Commissioner
AMA Privacy Framework
Augmented Intelligence (AI)/Information Blocking and Interoperability
Opioids
EHR Certification
Quality Payment Program burdens
Data Privacy
42 CFR Part 2
Nondiscrimination
Anti-transgender violence
Disaggregation of health outcomes related to Asian American and Pacific Islander (AAPI) Data
Flavored e-cigarettes/Vaping
Schedule II drugs/Annual production quota reduction
Telehealth
Drug Pricing/Transparency
Drug Compounding
Software as a Medical Device (SaMD)
Health Disparities
Physician economic impact

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Health & Human Services - Dept of (HHS), Federal Trade Commission (FTC), Drug Enforcement Administration (DEA), Centers For Disease Control & Prevention (CDC), Substance Abuse & Mental Health Services Administration (SAMHSA), Commerce - Dept of (DOC), President of the U.S., Federal Bureau of Investigation (FBI), White House Office, Justice - Dept of (DOJ), Food & Drug Administration (FDA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code IMM

16. Specific lobbying issues

H.R. 2895, Conrad State 30 and Physician Access Reauthorization Act, all provisions
S. 948, Conrad State 30 and Physician Access Reauthorization Act, all provisions
Immigration Detainees/DNA-Sample Collection
Public Charge
Immigrant health insurance coverage
Immigration

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Justice - Dept of (DOJ), State - Dept of (DOS), President of the U.S., Homeland Security - Dept of (DHS)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code LBR

16. Specific lobbying issues

Health Insurance Industry Competition

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code MMM

16. Specific lobbying issues

H.R. 4932, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
S. 2741, Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) for Health Act of 2019, all provisions
H.R. 3414, Opioid Workforce Act of 2019, all provisions
S. 2892, Opioid Workforce Act of 2019, all provisions
H.R. 3, Elijah E. Cummings Lower Drug Costs Now Act, provisions relating to drug pricing transparency, incorporating value into drug pricing, reducing prior authorization burdens, physician samples
H.R. 3107, Improving Seniors' Timely Access to Care Act of 2019, all provisions
H.R. 1948, Lymphedema Treatment Act of 2019, all provisions
S. 518, Lymphedema Treatment Act of 2019, all provisions
H.R. 1570, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions
S. 668, Removing Barriers to Colorectal Cancer Screening Act of 2019, all provisions
H.R. 1329, Medicaid Reentry Act, all provisions
S. 2648, Rural ACO Improvement Act, all provisions
H.R. 19, Lower Costs, More Cures Act of 2019, all provisions
S. 348, Resident Physician Shortage Reduction Act of 2019, all provisions

Medicare program: Protecting Access to Medicare Act (PAMA)/lab coding
Medicare program: Medicare Care Coordination Improvement Act
Medicare program: Protecting and Improving Medicare for our Nations Seniors, Section 5
Medicare program: Appropriate Use Criteria (AUC) G-Codes and modifiers
Medicare program: Medicare physician payment update
Medicare program: Regulatory relief
Medicare program: Medicare for All
Medicare program: Stark Law and Anti-Kickback Statute
Medicare program: Health IT burdens
Medicare program: Merit-based Incentive Payment System (MIPS)
Medicare program: Data Privacy
Medicare program: Alternative Payment Models (APMs)
Medicare program: Accountable Care Organizations (ACOs)
Medicare program: Pre-diabetes test coverage
Medicare program: Patient Access and Interoperability
Medicare program: Prior Authorization
Medicare program: Evaluation and Management(E/M)
Medicare program: Graduate Medical Education/Cap-Flexibility
Medicare program: Pharmacy Benefits Manager (PBM)/Rx drug price transparency
Medicare program: Primary Care First/medical oncology, radiation oncology, diabetes prevention
Medicare program: Medicare Diabetes Prevention Program
Medicare program: Open Payments
Medicare program: CMS Provider Compliance & Regulatory Relief
Medicare program: PECOS Enrollment/Revalidation
Medicare and Medicaid programs: Opioids/medication-assisted treatment
Medicare and Medicaid programs: Quality Payment Program
Medicare and Medicaid programs: Medicare Access and Chip Reauthorization Act (MACRA) implementation/technical improvements/physician payments
Medicaid program: Idaho Medicaid Reform Waiver
Medicaid program: Funding and maternal mortality

17. House(s) of Congress and Federal agencies Check if None

U.S. SENATE, U.S. HOUSE OF REPRESENTATIVES, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Natl Drug Control Policy (NDCP)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

LOBBYING ACTIVITY. Select as many codes as necessary to reflect the general issue areas in which the registrant engaged in lobbying on behalf of the client during the reporting period. Using a separate page for each code, provide information as requested. Add additional page(s) as needed.

15. General issue area code VET

16. Specific lobbying issues

Scope of Practice
Veterans Choice/Community Care Program
Tricare Access

17. House(s) of Congress and Federal agencies Check if None

Veterans Affairs - Dept of (VA)

18. Name of each individual who acted as a lobbyist in this issue area

19. Interest of each foreign entity in the specific issues listed on line 16 above Check if None

​

Information Update Page - Complete ONLY where registration information has changed.

20. Client new address

21. Client new principal place of business (if different than line 20)

22. New General description of client’s business or activities

LOBBYIST UPDATE

23. Name of each previously reported individual who is no longer expected to act as a lobbyist for the client

ISSUE UPDATE

24. General lobbying issue that no longer pertains

AFFILIATED ORGANIZATIONS

25. Add the following affiliated organization(s)

Internet Address:

26. Name of each previously reported organization that is no longer affiliated with the registrant or client

FOREIGN ENTITIES

27. Add the following foreign entities:

28. Name of each previously reported foreign entity that no longer owns, or controls, or is affiliated with the registrant, client or affiliated organization

CONVICTIONS DISCLOSURE

29. Have any of the lobbyists listed on this report been convicted in a Federal or State Court of an offense involving bribery, extortion, embezzlement, an illegal kickback, tax evasion, fraud, a conflict of interest, making a false statement, perjury, or money laundering?
No Yes